Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis-Reference-Cited by-同舟云学术

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis

Published:2023-02-04 Issue:3 Volume:13 Page:803-816
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Augustin Matthias^ORCID,Bauer Andrea,Ertner Konstantin,von Kiedrowski Ralph,Schenck Florian,Ramaker-Brunke Jutta,Möller Sophie,Fait Anja,Bastian Mike^ORCID,Thaçi Diamant^ORCID

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-023-00894-3.pdf

Reference33 articles.

1. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109–22.

2. Buzney CD, Gottlieb AB, Rosmarin D. Asthma and atopic dermatitis: a review of targeted inhibition of interleukin-4 and interleukin-13 as therapy for atopic disease. J Drugs Dermatol. 2016;15:165–71.

3. de Bruin-Weller M, Gadkari A, Auziere S, et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol. 2020;34:1026–36.

4. Eckert L, Gupta S, Gadkari A, Mahajan P, Gelfand JM. Burden of illness in adults with atopic dermatitis: analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom. J Am Acad Dermatol. 2019;81:187–95.

5. Sanofi. Dupixent® summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_en.pdf. Accessed 16 Mar 2022.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis;Dermatology and Therapy;2024-06-26

2. Use of Dupilumab in Pediatric Patients: A Review;Current Pediatrics Reports;2024-06-20

3. Exploring the Potential of IL-4 and IL-13 Plasma Levels as Biomarkers in Atopic Dermatitis;Life;2024-03-07

4. Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis;Farmacia Hospitalaria;2023-07

5. [Artículo traducido] Consenso de la Sociedad Española de Farmacia Hospitalaria sobre el manejo fármacoterapéutico óptimo de la dermatitis atópica;Farmacia Hospitalaria;2023-07